This recognition celebrates our commitment to innovation in healthcare and acknowledges the impact of our virtual care model, which is transforming the way patients access long-term condition management.
The award was given for our groundbreaking collaboration with South East London ICB, where we delivered scalable, virtual-first care to support cardiovascular disease (CVD) prevention across the region. By integrating with primary care services, we provided patients with personalised, proactive care, whilst helping reduce the burden on GPs and improving patient health outcomes.
Our work with South East London ICB is a shining example of how virtual care can create tangible improvements for both patients and healthcare providers. Through our partnership, we have:
- Engaged thousands of patients who needed intervention for high blood pressure and cardiovascular risk managemen
- Improved clinical outcomes by supporting medication adherence and lifestyle changes
- Reduced GP workload, allowing primary care teams to focus on complex cases
- Proven the power of digital health solutions in tackling major public health challenges
You can read the full South East London ICB case study here to learn more about how this initiative is driving real change.
Winning this award is not just a milestone for Suvera, it’s a sign that virtual-first care is the future of healthcare. As we continue to expand our impact, we remain committed to collaborating with the NHS and other healthcare partners to deliver patient-centred, tech-enabled care that improves health outcomes at scale.
We want to thank HTN, our dedicated team, our NHS partners, and most importantly, the patients we serve. This recognition fuels our passion to keep innovating and making high-quality care more accessible for all.
If you're a healthcare provider looking to enhance patient outcomes while reducing workforce pressures and healthcare costs, consider partnering with Suvera. Our virtual clinics offer an end-to-end solution for primary care, from case-finding and patient engagement to condition and medication reviews. To learn more about partnership opportunities, get in touch using the link below.
